Abstract
Background: The Duke Treadmill Score (DTS) is an established clinical tool for risk stratification of coronary artery disease. We sought to assess the prognostic value of the DTS in diabetics compared with nondiabetics in this study. Methods: We studied 100 diabetics and 202 age- and sex-matched nondiabetic controls without known coronary artery disease risk stratified by DTS and followed for a median duration of 6.6 years. The association between DTS and primary, secondary outcomes, composite events, and rate of coronary angiography was tested. Results: Survival free from cardiac death, nonfatal myocardial infarction, congestive heart failure, or early and late revascularization was 89%, 54%, and 13%, respectively, in the low-, intermediate-, and high-risk categories of diabetic group (P <.0001), and 91%, 57%, and 17%, respectively, in the low- to high-risk groups of nondiabetics (P <.0001). During follow-up, diabetics had more secondary events (P = .011) and coronary angiography (P <.001) compared with nondiabetics. The DTS was a strong independent predictor of composite events in both diabetics (P <.001) and nondiabetics (P <.001). A significant number of diabetics were classified as intermediate risk and had a significantly higher incidence of coronary angiography (87.5% vs 70.8%, P = .032) and late revascularizations (35.4% vs 15.3%, P = .011) within this risk group compared with nondiabetics. Survival free from major adverse cardiac events differed significantly across the 3 Duke risk groups for diabetics (P = .002) but not for controls (P = .07). Survival free from composite events differed significantly across the 3 Duke risk groups for both diabetics and nondiabetics (P <.0001). Overall, diabetics had higher rates of major adverse cardiac events, composite events (P = .011), and coronary angiography (P <.001) than nondiabetics. The DTS is a strong predictor of survival free of composite events in both groups by multivariate analysis. Conclusions: The DTS predicted survival free from MACE and composite events equally well in patients with and without diabetes.
| Original language | English |
|---|---|
| Pages (from-to) | 516-521 |
| Number of pages | 6 |
| Journal | American Heart Journal |
| Volume | 150 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2005 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Cite this
Prognostic value of the Duke Treadmill Score in diabetic patients. / Lakkireddy, Dhanunjaya R.; Bhakkad, Jyothi; Korlakunta, Hema L.; Ryschon, Kay; Shen, Xuedong; Mooss, Aryan N.; Mohiuddin, Syed M.
In: American Heart Journal, Vol. 150, No. 3, 09.2005, p. 516-521.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Prognostic value of the Duke Treadmill Score in diabetic patients
AU - Lakkireddy, Dhanunjaya R.
AU - Bhakkad, Jyothi
AU - Korlakunta, Hema L.
AU - Ryschon, Kay
AU - Shen, Xuedong
AU - Mooss, Aryan N.
AU - Mohiuddin, Syed M.
PY - 2005/9
Y1 - 2005/9
N2 - Background: The Duke Treadmill Score (DTS) is an established clinical tool for risk stratification of coronary artery disease. We sought to assess the prognostic value of the DTS in diabetics compared with nondiabetics in this study. Methods: We studied 100 diabetics and 202 age- and sex-matched nondiabetic controls without known coronary artery disease risk stratified by DTS and followed for a median duration of 6.6 years. The association between DTS and primary, secondary outcomes, composite events, and rate of coronary angiography was tested. Results: Survival free from cardiac death, nonfatal myocardial infarction, congestive heart failure, or early and late revascularization was 89%, 54%, and 13%, respectively, in the low-, intermediate-, and high-risk categories of diabetic group (P <.0001), and 91%, 57%, and 17%, respectively, in the low- to high-risk groups of nondiabetics (P <.0001). During follow-up, diabetics had more secondary events (P = .011) and coronary angiography (P <.001) compared with nondiabetics. The DTS was a strong independent predictor of composite events in both diabetics (P <.001) and nondiabetics (P <.001). A significant number of diabetics were classified as intermediate risk and had a significantly higher incidence of coronary angiography (87.5% vs 70.8%, P = .032) and late revascularizations (35.4% vs 15.3%, P = .011) within this risk group compared with nondiabetics. Survival free from major adverse cardiac events differed significantly across the 3 Duke risk groups for diabetics (P = .002) but not for controls (P = .07). Survival free from composite events differed significantly across the 3 Duke risk groups for both diabetics and nondiabetics (P <.0001). Overall, diabetics had higher rates of major adverse cardiac events, composite events (P = .011), and coronary angiography (P <.001) than nondiabetics. The DTS is a strong predictor of survival free of composite events in both groups by multivariate analysis. Conclusions: The DTS predicted survival free from MACE and composite events equally well in patients with and without diabetes.
AB - Background: The Duke Treadmill Score (DTS) is an established clinical tool for risk stratification of coronary artery disease. We sought to assess the prognostic value of the DTS in diabetics compared with nondiabetics in this study. Methods: We studied 100 diabetics and 202 age- and sex-matched nondiabetic controls without known coronary artery disease risk stratified by DTS and followed for a median duration of 6.6 years. The association between DTS and primary, secondary outcomes, composite events, and rate of coronary angiography was tested. Results: Survival free from cardiac death, nonfatal myocardial infarction, congestive heart failure, or early and late revascularization was 89%, 54%, and 13%, respectively, in the low-, intermediate-, and high-risk categories of diabetic group (P <.0001), and 91%, 57%, and 17%, respectively, in the low- to high-risk groups of nondiabetics (P <.0001). During follow-up, diabetics had more secondary events (P = .011) and coronary angiography (P <.001) compared with nondiabetics. The DTS was a strong independent predictor of composite events in both diabetics (P <.001) and nondiabetics (P <.001). A significant number of diabetics were classified as intermediate risk and had a significantly higher incidence of coronary angiography (87.5% vs 70.8%, P = .032) and late revascularizations (35.4% vs 15.3%, P = .011) within this risk group compared with nondiabetics. Survival free from major adverse cardiac events differed significantly across the 3 Duke risk groups for diabetics (P = .002) but not for controls (P = .07). Survival free from composite events differed significantly across the 3 Duke risk groups for both diabetics and nondiabetics (P <.0001). Overall, diabetics had higher rates of major adverse cardiac events, composite events (P = .011), and coronary angiography (P <.001) than nondiabetics. The DTS is a strong predictor of survival free of composite events in both groups by multivariate analysis. Conclusions: The DTS predicted survival free from MACE and composite events equally well in patients with and without diabetes.
UR - http://www.scopus.com/inward/record.url?scp=24944529981&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=24944529981&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2004.09.058
DO - 10.1016/j.ahj.2004.09.058
M3 - Article
VL - 150
SP - 516
EP - 521
JO - American Heart Journal
JF - American Heart Journal
SN - 0002-8703
IS - 3
ER -